Selle Barbara, Furtwängler Rhoikos, Graf Norbert, Kaatsch Peter, Bruder Elisabeth, Leuschner Ivo
Department of Pediatric Hematology and Oncology, St. Annastift Children's Hospital, Ludwigshafen, Germany.
Cancer. 2006 Dec 15;107(12):2906-14. doi: 10.1002/cncr.22346.
Childhood renal cell carcinomas (RCCs) differ histologically and biologically from their adult counterparts. The characteristics of RCC-affected children and their tumors, the influence of treatment, and outcome have so far not been studied in a nonselected, population-based cohort.
A retrospective analysis was undertaken of RCC patients less than 16 years old reported to the German Childhood Cancer Registry and to the Kiel Paediatric Tumor Registry from 1980 to 2005.
Forty-nine RCC in children (24 boys, 25 girls) with a median age of 10.6 years were identified. In about every third child possibly RCC-related underlying disorders (tuberous sclerosis, neuroblastoma, teratoma with chemotherapy, Saethre-Chotzen syndrome, chronic renal failure) or related diseases in their family were found. The pathologic subtypes were papillary in 16 (33%), translocation type in 11 (22%), unclassified in 8 (16%), and rarely clear-cell (n = 3) or others. Thirty-four (69%) patients had localized RCC, 8 (16%) patients regional lymph node metastases, and 4 (8%) patients distant metastases. Event-free survival and overall survival rates at 5 years were 96% for localized RCC, 69% and 75% for regional lymph node-positive, 25% and 33% for distant metastatic RCC, respectively. Two of 4 patients with distant metastases received immunotherapy combined with chemotherapy and surgery, both are alive, 1 of them disease-free for 6.9 years.
Pediatric RCCs are predominantly localized diseases. Children with RCC frequently suffer underlying disorders. Survival rates in localized and regional lymph node-positive cases are favorable. Because of the rarity of RCC in childhood, an international study is necessary.
儿童肾细胞癌(RCC)在组织学和生物学上与成人肾细胞癌不同。迄今为止,尚未在未经选择的、基于人群的队列中研究受RCC影响的儿童及其肿瘤的特征、治疗的影响和预后。
对1980年至2005年向德国儿童癌症登记处和基尔儿科肿瘤登记处报告的16岁以下RCC患者进行回顾性分析。
确定了49例儿童RCC(24例男孩,25例女孩),中位年龄为10.6岁。大约每三分之一的儿童可能存在与RCC相关的潜在疾病(结节性硬化症、神经母细胞瘤、化疗后的畸胎瘤、塞-乔综合征、慢性肾衰竭)或其家族中的相关疾病。病理亚型为乳头状16例(33%)、易位型11例(22%)、未分类8例(16%),很少为透明细胞型(n = 3)或其他类型。34例(69%)患者为局限性RCC,8例(16%)患者有区域淋巴结转移,4例(8%)患者有远处转移。局限性RCC患者5年无事件生存率和总生存率分别为96%,区域淋巴结阳性患者为69%和75%,远处转移性RCC患者为25%和33%。4例远处转移患者中有2例接受了免疫治疗联合化疗和手术,均存活,其中1例无病生存6.9年。
儿童RCC主要为局限性疾病。患有RCC的儿童经常患有潜在疾病。局限性和区域淋巴结阳性病例的生存率良好。由于儿童RCC罕见,有必要进行国际研究。